Cargando…

ESRRG promoter hypermethylation as a diagnostic and prognostic biomarker in laryngeal squamous cell carcinoma

BACKGROUND: Estrogen‐related receptor gamma (ESRRG) has been identified as a tumor suppressor gene in several cancers. We aimed to evaluate ESRRG promoter methylation in laryngeal squamous cell carcinoma (LSCC) and its relative clinical value in LSCC. METHODS: Bisulfite pyrosequencing assays were pe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Zhisen, Hu, Yan, Zhou, Chongchang, Yuan, Jie, Xu, Jie, Hao, Wenjuan, Deng, Hongxia, Ye, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642328/ https://www.ncbi.nlm.nih.gov/pubmed/31002184 http://dx.doi.org/10.1002/jcla.22899

Ejemplares similares

LZTS2 promoter hypermethylation: a potential biomarker for the diagnosis and prognosis of laryngeal squamous cell carcinoma
por: Shen, Zhisen, et al.
Publicado: (2018)

SHISA3 Promoter Methylation Is a Potential Diagnostic and Prognostic Biomarker for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

The Clinical Signification of Claudin-11 Promoter Hypermethylation for Laryngeal Squamous Cell Carcinoma
por: Shen, Zhisen, et al.
Publicado: (2017)

SSTR2 promoter hypermethylation is associated with the risk and progression of laryngeal squamous cell carcinoma in males
por: Shen, Zhisen, et al.
Publicado: (2016)

ITGA5 is an independent prognostic biomarker and potential therapeutic target for laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Long non-coding RNA AC023794.4-201 exerts a tumor-suppressive function in laryngeal squamous cell cancer and may serve as a potential prognostic biomarker
por: Shen, Zhisen, et al.
Publicado: (2020)

The clinical significance of HOXA9 promoter hypermethylation in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2019)

tRNA(Ini) (CAT) inhibits proliferation and promotes apoptosis of laryngeal squamous cell carcinoma cells
por: Li, Jun, et al.
Publicado: (2021)

A novel pyroptosis-related gene signature to predict outcomes in laryngeal squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Long non-coding RNA AC026166.2-001 inhibits cell proliferation and migration in laryngeal squamous cell carcinoma by regulating the miR-24-3p/p27 axis
por: Shen, Zhisen, et al.
Publicado: (2018)

CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma
por: Wei, Zhengyu, et al.
Publicado: (2022)

Diagnostic and prognostic value of FOXD1 expression in head and neck squamous cell carcinoma
por: Qiu, Shijie, et al.
Publicado: (2021)

Identification of a new anoikis-related gene signature for prognostic significance in head and neck squamous carcinomas
por: Wei, Zhengyu, et al.
Publicado: (2023)

The association, clinicopathological significance, and diagnostic value of CDH1 promoter methylation in head and neck squamous cell carcinoma: a meta-analysis of 23 studies
por: Shen, Zhisen, et al.
Publicado: (2016)

A systematic review and meta-analysis approach on diagnostic value of MLH1 promoter methylation for head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
por: Shen, Yiming, et al.
Publicado: (2022)

High P4HA1 expression is an independent prognostic factor for poor overall survival and recurrent‐free survival in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2019)

Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC
por: Shen, Zhisen, et al.
Publicado: (2014)

Expression Profile and Prognostic Values of HOXA Family Members in Laryngeal Squamous Cell Cancer
por: Li, Jinyun, et al.
Publicado: (2020)

Predicting the prognosis, immune response, and immunotherapy in head and neck squamous cell carcinoma using a novel risk model based on anoikis-related lncRNAs
por: Deng, Hongxia, et al.
Publicado: (2023)

A novel Pyroptosis‐related long non‐coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2022)

Expression of the long noncoding RNA RP11‐169D4.1‐001 in Hypopharyngeal Squamous cell carcinoma tissue and its clinical significance
por: Shen, Zhisen, et al.
Publicado: (2019)

MicroRNA-145 inhibits growth of laryngeal squamous cell carcinoma by targeting the PI3K/Akt signaling pathway
por: Ye, Dong, et al.
Publicado: (2019)

MiR-182 regulates cell proliferation and apoptosis in laryngeal squamous cell carcinoma by targeting the CRR9
por: Lv, Yuan, et al.
Publicado: (2019)

Arylsulfatase I is a prognostic biomarker for head and neck squamous cell carcinoma and Pan‐cancer
por: Shen, Yiming, et al.
Publicado: (2022)

Construction of an m6A‐related lncRNA pair prognostic signature and prediction of the immune landscape in head and neck squamous cell carcinoma
por: Zhou, Chongchang, et al.
Publicado: (2021)

Pyroptosis patterns and immune infiltrates characterization in head and neck squamous cell carcinoma
por: Deng, Hongxia, et al.
Publicado: (2022)

Identification of immune‐related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma
por: Li, Qun, et al.
Publicado: (2022)

RB1 loss triggers dependence on ESRRG in retinoblastoma
por: Field, Matthew G., et al.
Publicado: (2022)

Identification and validation of a novel signature based on T cell marker genes to predict prognosis, immunotherapy response and chemotherapy sensitivity in head and neck squamous carcinoma by integrated analysis of single-cell and bulk RNA-sequencing
por: Zhou, Chongchang, et al.
Publicado: (2023)

Epigenomic Elements Analyses for Promoters Identify ESRRG as a New Susceptibility Gene for Obesity-related Traits
por: Dong, Shan-Shan, et al.
Publicado: (2016)

Early diagnostic potential of APC hypermethylation in esophageal cancer
por: Wang, Bujiang, et al.
Publicado: (2018)

Promoter hypermethylation-induced transcriptional down-regulation of the gene MYCT1 in laryngeal squamous cell carcinoma
por: Yang, Min, et al.
Publicado: (2012)

Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated β-catenin degradation in gastric cancer
por: Peng, Zhiyang, et al.
Publicado: (2020)

ESRRG, ATP4A, and ATP4B as Diagnostic Biomarkers for Gastric Cancer: A Bioinformatic Analysis Based on Machine Learning
por: Chen, Qiu, et al.
Publicado: (2022)

Promoter hypermethylation of CD133/PROM1 is an independent poor prognosis factor for head and neck squamous cell carcinoma
por: Hu, Zele, et al.
Publicado: (2020)

Downregulation of thrombospondin-1 by DNA hypermethylation is associated with tumor progression in laryngeal squamous cell carcinoma
por: Huang, Chuang, et al.
Publicado: (2016)

Single-cell transcriptomic landscapes of a rare human laryngeal chondrosarcoma
por: Lin, Chen, et al.
Publicado: (2021)

ESRRG and PERM1 Govern Mitochondrial Conversion in Brite/Beige Adipocyte Formation
por: Müller, Sebastian, et al.
Publicado: (2020)

Lupus susceptibility gene Esrrg modulates regulatory T cells through mitochondrial metabolism
por: Li, Wei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ji541f7750tolf9l650asvckkc